flibanserin: sample size [Design Issues]

posted by mokhtar saleh – Egypt, 2018-10-28 12:34 (908 d 00:09 ago) – Posting: # 19497
Views: 1,637

Are there any recommendations for same size calculations for flibanserin Bioequivalence study as there are no data about intra subject variability ??


Edit: Category changed and subject line changed; see also this post #1, #2. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 22 (0 registered, 22 guests [including 3 identified bots]).
Forum time: Friday 13:43 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5